Our previous work indicated that the Kir5.1 mutation in the kidney led to a complex cardiorenal phenotype, including low body weight, renin-angiotensin-aldosterone system dysregulation, hypokalemia, and protection from salt-induced hypertension with dietary K+ supplementation (18, 19). Here, KCNJ16 is linked to hypertensive disorder.